Acute pancreatitis

被引:37
作者
Harper, Simon J. F. [1 ]
Cheslyn-Curtis, Sarah [1 ]
机构
[1] Luton & Dunstable NHS Fdn Trust, Dept Pancreaticobiliar Surg, Luton LU4 0DZ, Beds, England
关键词
C-REACTIVE PROTEIN; TRYPSINOGEN ACTIVATION PEPTIDE; DRUG-INDUCED PANCREATITIS; NECROSIS-FACTOR-ALPHA; EARLY PREDICTION; ORGAN FAILURE; INFECTED NECROSIS; SERUM AMYLASE; LUNG INJURY; CELL-DEATH;
D O I
10.1258/acb.2010.010196
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Acute pancreatitis (AP) is an important cause of morbidity and mortality worldwide and the annual incidence appears to be increasing. It presents as a mild self-limiting illness in 80% of patients. However, one-fifth of these develop a severe complicated life-threatening disease requiring intensive and prolonged therapeutic intervention. Alcohol and gallstone disease remain the commonest causes of AP but metabolic abnormalities, obesity and genetic susceptibility are thought be increasingly important aetiological factors. The prompt diagnosis of AP and stratification of disease severity is essential in directing rapid delivery of appropriate therapeutic measures. In this review, the range of diagnostic and prognostic assays, severity scoring systems and radiological investigations used in current clinical practice are described, highlighting their strengths and weaknesses. Increased understanding of the complex pathophysiology of AP has generated an array of new potential diagnostic assays and these are discussed. The multidisciplinary approach to management of severe pancreatitis is outlined, including areas of controversy and novel treatments.
引用
收藏
页码:23 / 37
页数:15
相关论文
共 178 条
[1]   Severe acute pancreatitis: Pathogenetic aspects and prognostic factors [J].
Al Mofleh, Ibrahim A. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (05) :675-684
[2]   Clinical laboratory assessment of acute pancreatitis [J].
Al-Bahrani, AZ ;
Ammori, BJ .
CLINICA CHIMICA ACTA, 2005, 362 (1-2) :26-48
[3]  
Alfonso V, 2003, Gastroenterol Hepatol, V26, P288, DOI 10.1157/13046590
[4]  
[Anonymous], GUT
[5]   Activation peptide of carboxypeptidase B in serum and urine in acute pancreatitis [J].
Appelros, S ;
Thim, L ;
Borgström, A .
GUT, 1998, 42 (01) :97-102
[6]   LIPASE AND PANCREATIC AMYLASE ACTIVITIES IN TISSUES AND IN PATIENTS WITH HYPERAMYLASEMIA [J].
APPLE, F ;
BENSON, P ;
PREESE, L ;
EASTEP, S ;
BILODEAU, L ;
HEILER, G .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1991, 96 (05) :610-614
[7]   THE BILIARY-TRACT IN PATIENTS WITH ACUTE GALLSTONE PANCREATITIS [J].
ARMSTRONG, CP ;
TAYLOR, TV ;
JEACOCK, J ;
LUCAS, S .
BRITISH JOURNAL OF SURGERY, 1985, 72 (07) :551-555
[8]   Long-term follow-up of patients with acute hypertriglyceridemia-induced pancreatitis [J].
Athyros, VG ;
Giouleme, OI ;
Nikolaidis, NL ;
Vasiliadis, TV ;
Bouloukos, VI ;
Kontopoulos, AG ;
Eugenidis, NP .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2002, 34 (04) :472-475
[9]   Pancreatic phospholipase A2 activity in acute pancreatitis:: A prognostic marker for early identification of patients at risk [J].
Aufenanger, J ;
Samman, M ;
Quintel, M ;
Fassbender, K ;
Zimmer, W ;
Bertsch, T .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2002, 40 (03) :293-297
[10]   Drug-Induced Pancreatitis Incidence, Management and Prevention [J].
Balani, Anil R. ;
Grendell, James H. .
DRUG SAFETY, 2008, 31 (10) :823-837